In 2024, the trade exchange (includes international purchases and sales) of Nucleic Acids and their Salts, whether or not Chemically no Definite Constitution; others Heterocyclic Compounds was US$283M.
In 2024, the states with the most international sales in Nucleic Acids and their Salts, whether or not Chemically no Definite Constitution; others Heterocyclic Compounds were Nuevo León (US$20.7M), Morelos (US$15.8M), Ciudad de México (US$11.3M), Estado de México (US$9.96M), and Baja California (US$4.82M).
The states with the most international purchases in 2024 were Ciudad de México (US$63.7M), Estado de México (US$49.7M), Coahuila de Zaragoza (US$35.1M), Jalisco (US$17.4M), and Querétaro (US$12M).
In 2024, the main commercial destinations of Nucleic Acids and their Salts, whether or not Chemically no Definite Constitution; others Heterocyclic Compounds were United States (US$23.2M), Spain (US$7.97M), Ireland (US$4.87M), Brazil (US$4.52M), and Pakistan (US$3.84M).
The main commercial origins of Nucleic Acids and their Salts, whether or not Chemically no Definite Constitution; others Heterocyclic Compounds in 2024 were China (US$111M), India (US$29.8M), Germany (US$13.8M), United States (US$12.5M), and Switzerland (US$8.62M).
In the global context, the main exporting countries of Nucleic Acids and their Salts, whether or not Chemically no Definite Constitution; others Heterocyclic Compounds in 2022 were Ireland (US$9B), China (US$5.81B), and Switzerland (US$3.47B). In the same year, the main importing countries of Nucleic Acids and their Salts, whether or not Chemically no Definite Constitution; others Heterocyclic Compounds were United States (US$11.2B), Germany (US$3B), and Canada (US$1.64B).